A novel synbiotic formulation prevents calcium oxalate stones by restoring gut microbiota homeostasis
- Author: mycolabadmin
- 10/21/2025
- View Source
Summary
Background
Calcium oxalate nephrolithiasis is a highly prevalent renal disorder with limited preventive strategies. Growing evidence links gut microbiota dysbiosis to stone formation, suggesting microbiota modulation as a potential therapeutic approach. Synbiotic formulations combining probiotics and prebiotics show promise for mitigating hyperoxaluria and preventing renal stone formation.
Objective
This study evaluated the therapeutic potential of a novel synbiotic formulation containing Lactiplantibacillus plantarum, Lacticaseibacillus casei, Bifidobacterium breve, and galactooligosaccharides (GOS) in preventing calcium oxalate stone formation. The research aimed to elucidate the anti-nephrolithic mechanisms through investigation of gut microbiota restoration and oxalate homeostasis modulation.
Results
Conclusion
- Published in:BMC Microbiology,
- Study Type:Animal Study,
- Source: PMID: 41120928